Polylaminin: Brazil's Laminin-Based Therapy for Paralysis Enters Early Human Trials
Truth Rating
Unproven
Brazilian scientists began human trials for Polylaminin, a protein-based therapy aiming to regenerate spinal tissue.
Brazilian scientists began human trials for Polylaminin, a protein-based therapy aiming to regenerate spinal tissue.
🔥Hot Take:
- A 'biological glue' for the spine? Brazil's Polylaminin is entering the human arena! 🇧🇷
- Hope vs. Hype: The 72-hour window makes this a trauma tool, not a 'miracle cure' for long-term paralysis. ⏳
🔥Hot Take:
- •A 'biological glue' for the spine? Brazil's Polylaminin is entering the human arena! 🇧🇷
- •Hope vs. Hype: The 72-hour window makes this a trauma tool, not a 'miracle cure' for long-term paralysis. ⏳
Claim Breakdown:
📝 Fact Check: The research is led by Dr. Tatiana Coelho de Sampaio at UFRJ and has spanned nearly three decades. 🔬
Fact Check Date: February 23, 2026
IMPORTANT WARNING
Disclaimer: This tool provides general informational content and is not a substitute for personalised, professional advice.
Recent BS Checks